OCUL’s 52-Week Rollercoaster: From $5.78 to $11.77 – What’s Next for Investors?

ZM Stock

Ocular Therapeutix Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $11.77 on 10/28/24 and the lowest value was $5.78 on 03/04/25.

52-week price history of OCUL Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Ocular Therapeutix Inc’s current trading price is -8.62% away from its 52-week high, while its distance from the 52-week low is 86.00%. The stock’s price range during this period has spanned from $5.78 to $11.77. In the Healthcare sector, the Ocular Therapeutix Inc’s shares surpassed a trading volume of approximately 4.84 million for the day, which was noticeably higher compared to the average daily volume of 9.2.12 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Ocular Therapeutix Inc (OCUL) has experienced a quarterly rise of 70.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.71B and boasts a workforce of 274 employees.

Making Sense of Trading Volume and Moving Average Data

Examining OCUL’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for OCUL stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.28.

OCUL Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 61.32%.However, over the last six months, we can see a weaker performance of 22.83%. Over the last 30 days, the price of OCUL has fallen by 19.29%. And in the last five days, it has surged by 18.24%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.